Login / Signup

Sarcoidosis occurring during BRAF/MEK inhibitors is associated with paradoxical ERK activation in Erdheim-Chester patients.

A AmouraJ HarocheJ-F EmileS BareteZ Helias-RodzewiczF CharlotteT MaisonobeZ AmouraFleur Cohen-Aubart
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2019)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • signaling pathway
  • pi k akt
  • prognostic factors
  • cell proliferation
  • patient reported outcomes
  • metastatic colorectal cancer
  • wild type